LAKE FOREST, Ill., Jan. 11 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, in San Francisco.
The presentation is scheduled to begin at 9:30 a.m. Pacific time on Wednesday, Jan. 13, 2010, and will be followed by a separate Q&A session at 10:00 a.m. Pacific time. Both the presentation and Q&A sessions will be available to all interested parties through live audiocasts accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. Replays of both the presentation and Q&A webcasts will be available on the Hospira Web site approximately 24 hours after the live presentations for 30 days after the event.
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.